HAVCR2 and breast cancer: CD8+ TEX is critical in immune evasion and progression of BC, involving upregulation of inhibitory receptors (PD-1, CTLA-4, LAG-3, TIM-3), immunosuppressive cells and cytokines, transcriptional and epigenetic alterations, metabolic reprogramming, and exosome pathways.